Aims: Macropinocytosis has been implicated in atherosclerosis, cancer, allergic disorders, and other pathologies. Unfortunately, most currently available pharmacological inhibitors of macropinocytosis interrupt other endocytic processes and have non-specific endocytosis-independent effects. The goal of the present study was to perform a high-throughput screen (HTS) of FDA-approved drugs to identify new, clinically relevant inhibitors of macropinocytosis. Methods: In the present study, 640 FDA-approved compounds were tested for their ability to inhibit macropinocytosis. A series of secondary assays were performed to confirm inhibitory activity, determine IC 50 values, and investigate cell toxicity. The ability of identified hits to inhibit phagocytosis, clathrin- and caveolin-mediated endocytosis was also investigated. Scanning electron microscopy and molecular biology techniques were utilized to investigate the mechanisms by which selected compounds inhibit macropinocytosis. Results: The HTS campaign identified 14 compounds that at ~10 μM concentration inhibit >95% of macropinocytotic solute internalization. Our results demonstrated that three lead compounds, namely imipramine, phenoxybenzamine, and vinblastine, potently inhibit (IC 50 ≤ 130 nM) macropinocytosis without exerting cytotoxic effects or inhibiting other endocytic pathways. Mechanistically, we found that imipramine inhibits translocation of ADP-ribosylation factor 6 to the plasma membrane and prevents membrane ruffle formation, a critical early step leading to macropinocytosis. Imipramine inhibited macropinocytosis in multiple cell types, including cancer cells, dendritic cells, and macrophages. Finally, incubation of macrophages with imipramine inhibited nLDL macropinocytosis and foam cell formation in vitro . Innovation and Conclusion: The identified macropinocytosis inhibitors may prove useful as new pharmacological tools to more fully discern the role of macropinocytosis in pathological processes and as therapeutic agents in various disorders involving macropinocytosis.
Read full abstract